Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 376–390 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3861 INF2 Gene Focal Segmental Glomerulosclerosis Type 5 (FSGS5) Genetic Test This test evaluates the INF2 gene for pathogenic variants associated with autosomal dominant focal segmental glomerulosclerosis type 5 (FSGS5).	Peripheral Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the INF2 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["A clinical history form and genetic counselling session must be completed prior to sample collection.", "No fasting is required."] Indications ["Patients with steroid-resistant nephrotic syndrome", "Patients with unexplained proteinuria", "Patients with a family history of kidney disease", "Suspected familial FSGS"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: N04.1 Clinical summary This test evaluates the INF2 gene for pathogenic variants associated with autosomal dominant focal segmental glomerulosclerosis type 5 (FSGS5).
TEST-6084 INS Gene Maturity-Onset Diabetes of the Young Type 10 (MODY10) Genetic Test This test evaluates the INS gene for mutations associated with Maturity-Onset Diabetes of the Young Type 10 (MODY10).	Peripheral Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["INS gene mutations", "Pathogenic variants in the insulin gene"] Parameters [] Preparation ["No fasting required", "Genetic counselling recommended before sample collection"] Indications ["Suspected monogenic diabetes", "Early-onset diabetes", "Family history of MODY", "Differentiation from Type 1/Type 2 diabetes"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E13.9 Clinical summary This test evaluates the INS gene for mutations associated with Maturity-Onset Diabetes of the Young Type 10 (MODY10).
TEST-6220 INS Gene Type 1 Diabetes Genetic Test This test evaluates the insulin (INS) gene for pathogenic variants associated with early-onset Type 1 diabetes.	Peripheral Whole Blood, Buccal Swab, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the INS gene", "Coverage of coding exons, flanking intronic regions, and splice sites"] Parameters [] Preparation ["No fasting is strictly required.", "A mandatory pre-test genetic counselling session and pedigree chart construction must be completed prior to sample collection."] Indications ["Individuals with a strong family history of Type 1 diabetes", "Early-onset hyperglycemia", "Unexplained metabolic disturbances", "Pediatric patients", "Young adults", "Asymptomatic relatives of an affected proband", "Distinguishing Type 1 from Type 2 diabetes in atypical presentations"] Measurement technique Confirm with laboratory Codes LOINC: 77936-6 ICD-10: E10.9 Clinical summary This test evaluates the insulin (INS) gene for pathogenic variants associated with early-onset Type 1 diabetes.
TEST-4867 IRAK4 Gene Invasive Pneumococcal Disease (Recurrent, Isolated Type 1) Genetic Test This genetic test evaluates the IRAK4 gene for variants associated with IRAK-4 deficiency, a primary immunodeficiency.	Whole blood (EDTA), extracted genomic DNA, or FTA card dried blood spot	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IRAK4 gene sequence", "Pathogenic variants in IRAK4"] Parameters [] Preparation ["Submit detailed clinical history", "Provide available immunological workup results"] Indications ["Recurrent invasive pneumococcal infections beyond the second year of life", "Inadequate responses to polysaccharide-based vaccines"] Measurement technique Confirm with laboratory Codes LOINC: 81303-9 ICD-10: D82.8 Clinical summary This genetic test evaluates the IRAK4 gene for variants associated with IRAK-4 deficiency, a primary immunodeficiency.
TEST-3981 ISCU Gene‑Related Hereditary Myopathy with Lactic Acidosis Genetic Test This genetic test analyzes the ISCU gene for pathogenic variants associated with hereditary myopathy and lactic acidosis.	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ISCU gene variants", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"] Parameters [] Preparation [] Indications ["Suspected hereditary myopathy with lactic acidosis", "Diagnostic confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 21669-6 ICD-10: G71.3 Clinical summary This genetic test analyzes the ISCU gene for pathogenic variants associated with hereditary myopathy and lactic acidosis.
TEST-4904 ISG15 Gene Immunodeficiency Type 38 Genetic Test This genetic test evaluates the ISG15 gene for pathogenic variants associated with primary immunodeficiency type 38 (MSMD). It employs next-generation sequencing for comprehensive...	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ISG15 gene", "Coverage of coding exons and flanking intronic regions"] Parameters [] Preparation ["No special dietary or medication preparation is required unless specifically instructed by the genetic counsellor during the pre-telehealth session."] Indications ["Patients with unexplained mycobacterial infections", "Patients with severe viral illnesses", "Patients with recurrent skin lesions"] Measurement technique Confirm with laboratory Codes LOINC: 81265-3 ICD-10: D84.8 Clinical summary This genetic test evaluates the ISG15 gene for pathogenic variants associated with primary immunodeficiency type 38 (MSMD). It employs next-generation sequencing for comprehensive analysis.
TEST-4047 ITGA2 (Glycoprotein Ia) C807T Polymorphism Test This test evaluates the ITGA2 C807T polymorphism, a genetic variant influencing platelet function and thrombosis risk.	Peripheral Whole Blood (EDTA) or FTA Card Finger-Prick	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ITGA2 C807T Polymorphism", "Glycoprotein Ia Gene Genotype"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of high-dose anticoagulant use"] Indications ["Assessment of inherited cardiovascular risk", "Personalized prevention planning"] Measurement technique Confirm with laboratory Codes LOINC: 21679-5 ICD-10: Z13.89, Z82.49 Clinical summary This test evaluates the ITGA2 C807T polymorphism, a genetic variant influencing platelet function and thrombosis risk.
TEST-3135 ITGA2B (CD61) Gene Neonatal Alloimmune Thrombocytopenia Genetic Test This genetic test analyzes the ITGA2B gene to identify mutations associated with neonatal alloimmune thrombocytopenia (NAIT).	Peripheral Blood (Whole Blood, EDTA), Cheek Swab (Buccal Mucosa), or Dried Blood Spot on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ITGA2B gene sequence", "Pathogenic variants in ITGA2B"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Newborns with unexplained severe thrombocytopenia", "Parents with a previous NAIT-affected pregnancy", "Siblings of affected infants to assess carrier status"] Measurement technique Confirm with laboratory Codes LOINC: 82114-0 ICD-10: P61.0, D69.3, Z13.79 Clinical summary This genetic test analyzes the ITGA2B gene to identify mutations associated with neonatal alloimmune thrombocytopenia (NAIT).
TEST-3638 ITPR1 Gene Gillespie Syndrome Genetic Test This test uses Next-Generation Sequencing (NGS) to analyze the ITPR1 gene for variants associated with Gillespie syndrome.	Whole blood (EDTA tube), extracted genomic DNA (≥1 µg), or dried blood spot on FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ITPR1 gene sequence", "Pathogenic variants (SNVs, indels, splice-site alterations)"] Parameters [] Preparation ["No fasting required", "Continue all prescribed medications unless advised otherwise by physician"] Indications ["Suspected Gillespie syndrome", "Family history of Gillespie syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 94497-5 ICD-10: Q87.8 Clinical summary This test uses Next-Generation Sequencing (NGS) to analyze the ITPR1 gene for variants associated with Gillespie syndrome.
TEST-5781 ITPR1 Gene Spinocerebellar Ataxia Type 29 (SCA29) Genetic Test This test detects pathogenic variants in the ITPR1 gene, which are responsible for causing Spinocerebellar Ataxia Type 29 (SCA29).	Whole Blood, FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ITPR1 gene pathogenic variants", "Copy Number Variations (CNV) in ITPR1"] Parameters [] Preparation [] Indications ["Suspected Spinocerebellar Ataxia Type 29 (SCA29)", "Early-life balance and coordination difficulties", "Family history of SCA29"] Measurement technique Confirm with laboratory Codes LOINC: 82317-1 ICD-10: G11.0, G11.8 Clinical summary This test detects pathogenic variants in the ITPR1 gene, which are responsible for causing Spinocerebellar Ataxia Type 29 (SCA29).
TEST-3504 IYD Gene Thyroid Dyshormonogenesis Type 4 NGS Genetic Analysis Test This test identifies pathogenic variants in the IYD gene associated with thyroid dyshormonogenesis type 4.	Whole Blood (Peripheral)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the IYD gene", "SNVs, indels, and CNVs"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without physician consultation"] Indications ["Confirm genetic aetiology of congenital hypothyroidism", "Guide treatment", "Screen at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 94836-5 ICD-10: E03.1 Clinical summary This test identifies pathogenic variants in the IYD gene associated with thyroid dyshormonogenesis type 4.
TEST-4063 KARS1 Gene CMTRIB Genetic Test This genetic test evaluates the KARS1 gene for mutations associated with Charcot-Marie-Tooth disease type RIB (CMTRIB), a hereditary peripheral neuropathy.	Peripheral whole blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KARS1 gene mutations", "Pathogenic variants"] Parameters [] Preparation ["Complete clinical history documentation", "Three-generation pedigree chart session"] Indications ["Suspected Charcot-Marie-Tooth disease type RIB", "Family history of CMTRIB", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94219-8 ICD-10: G60.0 Clinical summary This genetic test evaluates the KARS1 gene for mutations associated with Charcot-Marie-Tooth disease type RIB (CMTRIB), a hereditary peripheral neuropathy.
TEST-2821 KAT6B Gene Genitopatellar Syndrome Genetic Test This genetic test identifies pathogenic mutations within the KAT6B gene associated with Genitopatellar Syndrome and related disorders.	Peripheral whole blood (EDTA) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KAT6B gene coding region", "Copy Number Variants (CNV) in KAT6B gene"] Parameters [] Preparation ["No fasting required", "Continue all regular medications", "Mandatory pre-test genetic counseling session"] Indications ["Suspected Genitopatellar Syndrome", "Suspected Ohdo Syndrome", "Developmental delay with dysmorphic features"] Measurement technique Confirm with laboratory Codes LOINC: 96205-0 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic mutations within the KAT6B gene associated with Genitopatellar Syndrome and related disorders.
TEST-5397 KBTBD13 Gene Nemaline Myopathy Type 6 Genetic Test This test identifies genetic variants in the KBTBD13 gene associated with Nemaline Myopathy Type 6.	Whole Blood, Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KBTBD13 gene"] Parameters [] Preparation [] Indications ["Diagnosis of Nemaline Myopathy Type 6", "Family planning for individuals with Nemaline Myopathy Type 6", "Personalized management of Nemaline Myopathy Type 6"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G71.2 Clinical summary This test identifies genetic variants in the KBTBD13 gene associated with Nemaline Myopathy Type 6.
TEST-4211 KCNH2 Gene Long QT Syndrome Type 2 Genetic Test This test identifies pathogenic variants in the KCNH2 gene associated with Long QT Syndrome Type 2 (LQT2).	Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNH2 gene", "Large deletions/duplications (CNVs) in KCNH2"] Parameters [] Preparation [] Indications ["Confirming clinical diagnosis of LQT2", "Guiding beta-blocker therapy", "Screening at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 21614-3 ICD-10: I45.81 Clinical summary This test identifies pathogenic variants in the KCNH2 gene associated with Long QT Syndrome Type 2 (LQT2).

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.